Virocan Therapeutics Private Limited - Company Profile

It is a chemicals private limited company based in Guntur, Andhra Pradesh, India, established in 2005.
2005 Guntur, Andhra Pradesh, India Active
Last Updated:
Access Report
About Virocan Therapeutics Private Limited

Virocan Therapeutics Private Limited, a active private limited company, was established on 18 August 2005 in Guntur, Andhra Pradesh, India. Engaging in chemical products within the chemicals sector, it holds CIN: U24239AP2005PTC047169. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹4.90 M and a paid-up capital of ₹4.90 M.

It upholds a compliant status. Its leadership includes Donald Willard Weaver (Director), Jose Edson Silva Pontes (Director), Sreenivasa Rao Batchu (Director). Past directors included Donald Willard Weaver, Ramesh Babu Batchu, Batchu Kiran Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Nh-5, Edulapalem, Prathipadu, Guntur, Andhra Pradesh, 522019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239AP2005PTC047169

  • Registration Number

    047169

  • Incorporation Date

    18 August 2005

  • Authorized Capital

    ₹4.90 M

  • Paid-Up Capital

    ₹4.90 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.90 M
  • Paid Up Capital ₹ 4.90 M
  • Company Age 20 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 46.10%
  • Ebitda **** 50.08%
  • Net Worth -13.23%
  • Total Assets -3.71%
Company report

Virocan Therapeutics Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Virocan Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Virocan Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Donald Willard Weaver Director 16 Apr 2012 Current
Jose Edson Silva Pontes Director 20 Jul 2014 Current
Sreenivasa Rao Batchu Director 21 Aug 2025 Current
Rajesh Dachepalli Manager 25 Sep 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 02 Jul 2014 Past
Pramod Abcsdd Additional Director 02 Jul 2014 Past
Pramod Abcsdd Director 12 Jan 2017 Past
Pramod Abcsdd Additional Director 06 Jan 2016 Past
Pramod Abcsdd Director 14 Sep 2018 Past
Pramod Abcsdd Manager - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Virocan Therapeutics.

Virocan Therapeutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 46.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.23%.

Virocan Therapeutics revenue growth over time
Virocan Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -3.71%
*******
*******
*******
*******
Profit or Loss
*******
 46.10%
*******
*******
*******
*******
Net Worth
*******
 -13.23%
*******
*******
*******
*******
EBITDA
*******
 50.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Virocan Therapeutics?

In 2017, Virocan Therapeutics had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Virocan Therapeutics?

Unlock and access historical data on people associated with Virocan Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Virocan Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Virocan Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Virocan Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Virocan Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Sreenivasa Rao Batchu was appointed as a Director was appointed as a Director on 21 Aug 2025 & has been associated with this company since 10 months 8 days . was completed.

  • Balance Sheet

    The activity Virocan Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was completed.

  • Director Appointment

    Progress on Jose Edson Silva Pontes was appointed as a Director was appointed as a Director on 20 Jul 2014 & has been associated with this company since 11 years 11 months . was documented.

  • Director Appointment

    Rajesh Dachepalli was appointed as a Manager was appointed as a Manager on 25 Sep 2013 & has been associated with this company since 12 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Donald Willard Weaver was appointed as a Director was appointed as a Director on 16 Apr 2012 & has been associated with this company since 14 years 2 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Virocan Therapeutics Private Limited?

The CIN of Virocan Therapeutics Private Limited is U24239AP2005PTC047169.

Where is Virocan Therapeutics Private Limited headquartered?

Virocan Therapeutics Private Limited is headquartered at Nh-5, Edulapalem, Prathipadu, Guntur, Andhra Pradesh, 522019.

When was Virocan Therapeutics Private Limited incorporated?

Virocan Therapeutics Private Limited was incorporated on 18 August 2005.

Who are the current directors of Virocan Therapeutics Private Limited?

The current directors of Virocan Therapeutics Private Limited are

What is the primary industry of Virocan Therapeutics Private Limited?

The primary industry of Virocan Therapeutics Private Limited is Chemicals.

Is Virocan Therapeutics Private Limited a listed company?

Virocan Therapeutics Private Limited is unlisted.

What is the capital structure of Virocan Therapeutics Private Limited?

The authorized capital of Virocan Therapeutics Private Limited is ₹4.90 M, and the paid-up capital is ₹4.90 M.

What is the compliance status of Virocan Therapeutics Private Limited?

The compliance status of Virocan Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available